MP0317
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MP0317, covering 2025-01-30 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma [Phase 2]